Q&A: What Do FDA’s Recent Medical App Approvals Mean For Industry?
Executive Summary
Marc Scheineson, a former US FDA associate commissioner who now heads Alston & Bird’s food and drug law practice, offered insight into the agency's latest moves in regulating medical apps and what industry should watch for.
You may also be interested in...
Q3 US Device Approvals Snapshot: Apps Up, Original PMAs Down
Mobile apps made major headway into the world of US FDA regulation in the third quarter, with de novo go-aheads for two Apple Watch heart-rhythm apps and the first FDA approval of a smartphone app to support contraception. Meanwhile, original PMA-approval volumes continue to lag in 2018. Here's an infographic to spotlight US device approval trends during the third quarter, July through September.
FDA Approves Birth Control Mobile App, Vaginal Ring
US FDA announced the approval of the first direct-to-consumer mobile medical app that can prevent pregnancy via fertility awareness tracking. The app, Natural Cycles, has been criticized in Europe after some users experienced unplanned pregnancies. On the same day, the agency approved the first contraceptive vaginal ring that can be reused for an entire year.
mHealth Regs: FDA Drafts Wellness, Accessories Guidance Docs
One proposal addresses regulatory policy for low-risk devices targeting "general wellness" and the other seeks to clarify how FDA intends to regulate products intended as accessories to devices. Mobile health developers have been on the lookout for both.